191 related articles for article (PubMed ID: 10885428)
1. Mast cells correlate with angiogenesis and poor outcome in stage I lung adenocarcinoma.
Imada A; Shijubo N; Kojima H; Abe S
Eur Respir J; 2000 Jun; 15(6):1087-93. PubMed ID: 10885428
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
[TBL] [Abstract][Full Text] [Related]
4. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Kojima H; Shijubo N; Abe S
Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
[TBL] [Abstract][Full Text] [Related]
5. Tumor angiogenesis and vascular endothelial growth factor expression in stage I lung adenocarcinoma.
Shibusa T; Shijubo N; Abe S
Clin Cancer Res; 1998 Jun; 4(6):1483-7. PubMed ID: 9626466
[TBL] [Abstract][Full Text] [Related]
6. The relationship of tryptase- and chymase-positive mast cells to angiogenesis in stage I non-small cell lung cancer.
Ibaraki T; Muramatsu M; Takai S; Jin D; Maruyama H; Orino T; Katsumata T; Miyazaki M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):617-21. PubMed ID: 16125954
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis and mast cells in non-Hodgkin's lymphoma: a strong correlation in angioimmunoblastic T-cell lymphoma.
Fukushima N; Satoh T; Sano M; Tokunaga O
Leuk Lymphoma; 2001 Aug; 42(4):709-20. PubMed ID: 11697501
[TBL] [Abstract][Full Text] [Related]
8. Association of vascular endothelial growth factor expression with intratumoral microvessel density and tumour cell proliferation in human epidermoid lung carcinoma.
Mattern J; Koomägi R; Volm M
Br J Cancer; 1996 Apr; 73(7):931-4. PubMed ID: 8611409
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
10. Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma.
Kojima H; Shijubo N; Yamada G; Ichimiya S; Abe S; Satoh M; Sato N
Cancer; 2005 Oct; 104(8):1668-77. PubMed ID: 16116610
[TBL] [Abstract][Full Text] [Related]
11. Different angiogenic pathways in human cervical cancers.
Tokumo K; Kodama J; Seki N; Nakanishi Y; Miyagi Y; Kamimura S; Yoshinouchi M; Okuda H; Kudo T
Gynecol Oncol; 1998 Jan; 68(1):38-44. PubMed ID: 9454658
[TBL] [Abstract][Full Text] [Related]
12. Expression of vascular endothelial growth factor (VEGF) and its two receptors (VEGF-R1-Flt1 and VEGF-R2-Flk1/KDR) in non-small cell lung carcinomas (NSCLCs): correlation with angiogenesis and survival.
Decaussin M; Sartelet H; Robert C; Moro D; Claraz C; Brambilla C; Brambilla E
J Pathol; 1999 Aug; 188(4):369-77. PubMed ID: 10440746
[TBL] [Abstract][Full Text] [Related]
13. VEGF, flt-1, and KDR/flk-1 as prognostic indicators in endometrial carcinoma.
Fine BA; Valente PT; Feinstein GI; Dey T
Gynecol Oncol; 2000 Jan; 76(1):33-9. PubMed ID: 10620438
[TBL] [Abstract][Full Text] [Related]
14. Chymase-positive mast cells in small sized adenocarcinoma of the lung.
Nagata M; Shijubo N; Walls AF; Ichimiya S; Abe S; Sato N
Virchows Arch; 2003 Oct; 443(4):565-73. PubMed ID: 12827514
[TBL] [Abstract][Full Text] [Related]
15. Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma.
Sawatsubashi M; Yamada T; Fukushima N; Mizokami H; Tokunaga O; Shin T
Virchows Arch; 2000 Mar; 436(3):243-8. PubMed ID: 10782883
[TBL] [Abstract][Full Text] [Related]
16. Frequent expression of the vascular endothelial growth factor in human non-small-cell lung cancers.
Takahama M; Tsutsumi M; Tsujiuchi T; Kido A; Okajima E; Nezu K; Tojo T; Kushibe K; Kitamura S; Konishi Y
Jpn J Clin Oncol; 1998 Mar; 28(3):176-81. PubMed ID: 9614439
[TBL] [Abstract][Full Text] [Related]
17. Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma.
Takanami I; Takeuchi K; Naruke M
Cancer; 2000 Jun; 88(12):2686-92. PubMed ID: 10870050
[TBL] [Abstract][Full Text] [Related]
18. Patterns of angiogenesis in nonsmall-cell lung carcinoma.
Offersen BV; Pfeiffer P; Hamilton-Dutoit S; Overgaard J
Cancer; 2001 Apr; 91(8):1500-9. PubMed ID: 11301398
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor is associated with neovascularization and influences progression of non-small cell lung carcinoma.
Fontanini G; Vignati S; Boldrini L; Chinè S; Silvestri V; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Clin Cancer Res; 1997 Jun; 3(6):861-5. PubMed ID: 9815760
[TBL] [Abstract][Full Text] [Related]
20. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
